

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cellular response to interleukin-15 (GO:0071350) | 7.21147652 |
| 2 | cytidine deamination (GO:0009972) | 6.87389989 |
| 3 | cytidine metabolic process (GO:0046087) | 6.87389989 |
| 4 | cytidine catabolic process (GO:0006216) | 6.87389989 |
| 5 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.86473263 |
| 6 | negative regulation of cell killing (GO:0031342) | 6.86473263 |
| 7 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.55498448 |
| 8 | response to interleukin-15 (GO:0070672) | 6.52219459 |
| 9 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 6.27512194 |
| 10 | regulation of gamma-delta T cell differentiation (GO:0045586) | 6.17310626 |
| 11 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.79754663 |
| 12 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.72597912 |
| 13 | negative T cell selection (GO:0043383) | 5.71300816 |
| 14 | interferon-gamma production (GO:0032609) | 5.63721481 |
| 15 | regulation of gamma-delta T cell activation (GO:0046643) | 5.59107144 |
| 16 | positive T cell selection (GO:0043368) | 5.50388711 |
| 17 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 5.41465198 |
| 18 | DNA deamination (GO:0045006) | 5.39536712 |
| 19 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 5.35773425 |
| 20 | activated T cell proliferation (GO:0050798) | 5.31048090 |
| 21 | negative regulation of T cell mediated immunity (GO:0002710) | 5.29880016 |
| 22 | T cell migration (GO:0072678) | 5.28665543 |
| 23 | regulation of T cell chemotaxis (GO:0010819) | 5.22802792 |
| 24 | positive regulation of T cell chemotaxis (GO:0010820) | 5.22802792 |
| 25 | positive thymic T cell selection (GO:0045059) | 5.17095423 |
| 26 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 5.10161634 |
| 27 | regulation of natural killer cell mediated immunity (GO:0002715) | 5.10161634 |
| 28 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 5.09360863 |
| 29 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 5.07907114 |
| 30 | negative thymic T cell selection (GO:0045060) | 5.07619052 |
| 31 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.92652501 |
| 32 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 4.89500280 |
| 33 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 4.78684235 |
| 34 | regulation of T cell mediated cytotoxicity (GO:0001914) | 4.71931716 |
| 35 | regulation of lymphocyte chemotaxis (GO:1901623) | 4.62685998 |
| 36 | positive regulation of cell killing (GO:0031343) | 4.62375175 |
| 37 | regulation of alpha-beta T cell proliferation (GO:0046640) | 4.57233725 |
| 38 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 4.50817705 |
| 39 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.50725629 |
| 40 | regulation of cell killing (GO:0031341) | 4.40366930 |
| 41 | thymic T cell selection (GO:0045061) | 4.31581137 |
| 42 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.27287060 |
| 43 | T cell selection (GO:0045058) | 4.23261926 |
| 44 | regulation of activation of Janus kinase activity (GO:0010533) | 4.14857444 |
| 45 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.08377278 |
| 46 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 4.04551042 |
| 47 | regulation of regulatory T cell differentiation (GO:0045589) | 4.03117647 |
| 48 | regulation of B cell differentiation (GO:0045577) | 4.00783456 |
| 49 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.91385479 |
| 50 | lymphocyte migration (GO:0072676) | 3.91275783 |
| 51 | positive regulation of defense response to virus by host (GO:0002230) | 3.89019070 |
| 52 | T cell mediated immunity (GO:0002456) | 3.87880300 |
| 53 | * cellular defense response (GO:0006968) | 3.86227007 |
| 54 | regulation of T cell tolerance induction (GO:0002664) | 3.83617853 |
| 55 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.77385073 |
| 56 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.76979359 |
| 57 | T cell receptor signaling pathway (GO:0050852) | 3.76175589 |
| 58 | lymphocyte chemotaxis (GO:0048247) | 3.74325501 |
| 59 | negative regulation of T cell apoptotic process (GO:0070233) | 3.74301519 |
| 60 | positive regulation of calcium-mediated signaling (GO:0050850) | 3.70307720 |
| 61 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.67412994 |
| 62 | positive regulation of tolerance induction (GO:0002645) | 3.62555062 |
| 63 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.59742077 |
| 64 | negative regulation of adaptive immune response (GO:0002820) | 3.58323902 |
| 65 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.56066981 |
| 66 | negative regulation of interleukin-12 production (GO:0032695) | 3.47916986 |
| 67 | positive regulation of granulocyte differentiation (GO:0030854) | 3.47511189 |
| 68 | positive regulation of lymphocyte migration (GO:2000403) | 3.46389430 |
| 69 | negative regulation of alpha-beta T cell activation (GO:0046636) | 3.44512581 |
| 70 | regulation of histone H3-K27 methylation (GO:0061085) | 3.44337508 |
| 71 | positive regulation of B cell differentiation (GO:0045579) | 3.44222825 |
| 72 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.44020254 |
| 73 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.40432174 |
| 74 | positive regulation of T cell mediated immunity (GO:0002711) | 3.37494349 |
| 75 | mast cell activation (GO:0045576) | 3.34165862 |
| 76 | negative regulation by host of viral transcription (GO:0043922) | 3.30705236 |
| 77 | regulation of tolerance induction (GO:0002643) | 3.30103510 |
| 78 | natural killer cell activation (GO:0030101) | 3.26338237 |
| 79 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.26113466 |
| 80 | negative regulation of viral genome replication (GO:0045071) | 3.25093500 |
| 81 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.24826019 |
| 82 | positive regulation of lymphocyte mediated immunity (GO:0002708) | 3.23350256 |
| 83 | regulation of T cell mediated immunity (GO:0002709) | 3.12402496 |
| 84 | pyrimidine nucleoside catabolic process (GO:0046135) | 3.11918200 |
| 85 | leukocyte aggregation (GO:0070486) | 3.10405217 |
| 86 | positive regulation of T cell cytokine production (GO:0002726) | 3.05126623 |
| 87 | positive regulation of T cell migration (GO:2000406) | 3.04571680 |
| 88 | dendritic cell chemotaxis (GO:0002407) | 3.02434142 |
| 89 | Peyers patch development (GO:0048541) | 3.00513241 |
| 90 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.00513241 |
| 91 | T cell costimulation (GO:0031295) | 3.00206566 |
| 92 | T cell differentiation (GO:0030217) | 2.98891324 |
| 93 | T-helper cell differentiation (GO:0042093) | 2.97707687 |
| 94 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.97707687 |
| 95 | regulation of alpha-beta T cell activation (GO:0046634) | 2.97249799 |
| 96 | alpha-beta T cell differentiation (GO:0046632) | 2.97247849 |
| 97 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.97055842 |
| 98 | positive regulation of humoral immune response (GO:0002922) | 2.96870968 |
| 99 | lymphocyte costimulation (GO:0031294) | 2.96130278 |
| 100 | regulation of lymphocyte mediated immunity (GO:0002706) | 2.96061017 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 6.42029745 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 6.14150345 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.81903840 |
| 4 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.98617616 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.79370973 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.84719156 |
| 7 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.78030433 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.75599778 |
| 9 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.46751592 |
| 10 | MYB_26560356_Chip-Seq_TH2_Human | 3.35342584 |
| 11 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.05411164 |
| 12 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.80561017 |
| 13 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.78222044 |
| 14 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.71529178 |
| 15 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.44016830 |
| 16 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.37733624 |
| 17 | MYB_26560356_Chip-Seq_TH1_Human | 2.37379281 |
| 18 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.28212720 |
| 19 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.22162603 |
| 20 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.18153230 |
| 21 | GATA3_26560356_Chip-Seq_TH2_Human | 2.17989689 |
| 22 | MAF_26560356_Chip-Seq_TH1_Human | 2.16539805 |
| 23 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.96320568 |
| 24 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.94259078 |
| 25 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.84574246 |
| 26 | UTX_26944678_Chip-Seq_JUKART_Human | 1.82747771 |
| 27 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.82373305 |
| 28 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.81332939 |
| 29 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.75974047 |
| 30 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.74494518 |
| 31 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.65749577 |
| 32 | MAF_26560356_Chip-Seq_TH2_Human | 1.63785964 |
| 33 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.58227684 |
| 34 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49082995 |
| 35 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.47821455 |
| 36 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.46829420 |
| 37 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.44394150 |
| 38 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.38341989 |
| 39 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.36815037 |
| 40 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36305188 |
| 41 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.30320944 |
| 42 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.26812398 |
| 43 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.25706146 |
| 44 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.24266480 |
| 45 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.21403210 |
| 46 | GATA3_26560356_Chip-Seq_TH1_Human | 1.20104622 |
| 47 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.19882058 |
| 48 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.18779641 |
| 49 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.15294828 |
| 50 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.14299247 |
| 51 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.12677511 |
| 52 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.11510528 |
| 53 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.10060041 |
| 54 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.08576067 |
| 55 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.08328516 |
| 56 | SPI1_23127762_ChIP-Seq_K562_Human | 1.08325729 |
| 57 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.05934067 |
| 58 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.04391915 |
| 59 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.03260223 |
| 60 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.00548989 |
| 61 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.99384536 |
| 62 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.98096697 |
| 63 | VDR_22108803_ChIP-Seq_LS180_Human | 0.97514438 |
| 64 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96393882 |
| 65 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.95780432 |
| 66 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95555394 |
| 67 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.95414026 |
| 68 | GATA1_22025678_ChIP-Seq_K562_Human | 0.94003779 |
| 69 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.91510294 |
| 70 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90887784 |
| 71 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.90866853 |
| 72 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.90172580 |
| 73 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.86918635 |
| 74 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.86896857 |
| 75 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.84500907 |
| 76 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.83572925 |
| 77 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.82956809 |
| 78 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.82941409 |
| 79 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.82867833 |
| 80 | MYC_22102868_ChIP-Seq_BL_Human | 0.82139224 |
| 81 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.81736397 |
| 82 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.81378990 |
| 83 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.80108553 |
| 84 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.79809263 |
| 85 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.79588282 |
| 86 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.79472558 |
| 87 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.78258635 |
| 88 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.77839763 |
| 89 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.76647317 |
| 90 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.76350485 |
| 91 | P300_27268052_Chip-Seq_Bcells_Human | 0.76240586 |
| 92 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.75263017 |
| 93 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.75159845 |
| 94 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.74376488 |
| 95 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.74182903 |
| 96 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.73583245 |
| 97 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.71420902 |
| 98 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.70079741 |
| 99 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.68983246 |
| 100 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.66199784 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 6.09996696 |
| 2 | MP0003763_abnormal_thymus_physiology | 4.65976193 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.91143639 |
| 4 | MP0006082_CNS_inflammation | 3.38634810 |
| 5 | MP0001800_abnormal_humoral_immune | 3.22972351 |
| 6 | MP0005000_abnormal_immune_tolerance | 3.09041526 |
| 7 | MP0002723_abnormal_immune_serum | 2.92454253 |
| 8 | MP0005387_immune_system_phenotype | 2.91106446 |
| 9 | MP0001790_abnormal_immune_system | 2.91106446 |
| 10 | MP0009785_altered_susceptibility_to | 2.90142249 |
| 11 | MP0002420_abnormal_adaptive_immunity | 2.85770308 |
| 12 | MP0001819_abnormal_immune_cell | 2.79932303 |
| 13 | MP0009333_abnormal_splenocyte_physiolog | 2.76269650 |
| 14 | MP0004381_abnormal_hair_follicle | 2.69702140 |
| 15 | MP0005025_abnormal_response_to | 2.62603243 |
| 16 | MP0000685_abnormal_immune_system | 2.62298509 |
| 17 | MP0003436_decreased_susceptibility_to | 2.51877883 |
| 18 | MP0002452_abnormal_antigen_presenting | 2.50995324 |
| 19 | MP0003866_abnormal_defecation | 2.48370424 |
| 20 | MP0003724_increased_susceptibility_to | 2.48100687 |
| 21 | MP0002166_altered_tumor_susceptibility | 2.43070755 |
| 22 | MP0002148_abnormal_hypersensitivity_rea | 2.37664105 |
| 23 | MP0002398_abnormal_bone_marrow | 2.35705943 |
| 24 | MP0002419_abnormal_innate_immunity | 2.26550600 |
| 25 | MP0000716_abnormal_immune_system | 2.22878615 |
| 26 | MP0000703_abnormal_thymus_morphology | 2.18094777 |
| 27 | MP0002006_tumorigenesis | 2.11533727 |
| 28 | MP0002405_respiratory_system_inflammati | 2.05409734 |
| 29 | MP0010155_abnormal_intestine_physiology | 2.01414141 |
| 30 | MP0000689_abnormal_spleen_morphology | 1.99376023 |
| 31 | MP0002722_abnormal_immune_system | 1.95104082 |
| 32 | MP0003045_fibrosis | 1.87914888 |
| 33 | MP0005075_abnormal_melanosome_morpholog | 1.77205593 |
| 34 | MP0001853_heart_inflammation | 1.75114718 |
| 35 | MP0004947_skin_inflammation | 1.72409798 |
| 36 | MP0002429_abnormal_blood_cell | 1.70612985 |
| 37 | MP0001845_abnormal_inflammatory_respons | 1.64211378 |
| 38 | MP0000569_abnormal_digit_pigmentation | 1.59018152 |
| 39 | MP0005310_abnormal_salivary_gland | 1.49160520 |
| 40 | MP0002163_abnormal_gland_morphology | 1.44833635 |
| 41 | MP0003448_altered_tumor_morphology | 1.41217747 |
| 42 | MP0005464_abnormal_platelet_physiology | 1.37087275 |
| 43 | MP0008469_abnormal_protein_level | 1.34747319 |
| 44 | MP0005377_hearing/vestibular/ear_phenot | 1.34574087 |
| 45 | MP0003878_abnormal_ear_physiology | 1.34574087 |
| 46 | MP0003300_gastrointestinal_ulcer | 1.30823378 |
| 47 | MP0003786_premature_aging | 1.25933467 |
| 48 | MP0001873_stomach_inflammation | 1.16998949 |
| 49 | MP0009764_decreased_sensitivity_to | 1.13072658 |
| 50 | MP0000858_altered_metastatic_potential | 1.07840619 |
| 51 | MP0003183_abnormal_peptide_metabolism | 1.02166696 |
| 52 | MP0003646_muscle_fatigue | 1.01253095 |
| 53 | MP0001533_abnormal_skeleton_physiology | 0.97351770 |
| 54 | MP0009763_increased_sensitivity_to | 0.94878154 |
| 55 | MP0002998_abnormal_bone_remodeling | 0.94607597 |
| 56 | MP0008877_abnormal_DNA_methylation | 0.89133137 |
| 57 | MP0008873_increased_physiological_sensi | 0.88950427 |
| 58 | MP0002019_abnormal_tumor_incidence | 0.88299432 |
| 59 | MP0002933_joint_inflammation | 0.86746229 |
| 60 | MP0000920_abnormal_myelination | 0.84460724 |
| 61 | MP0002132_abnormal_respiratory_system | 0.80716482 |
| 62 | MP0005379_endocrine/exocrine_gland_phen | 0.79425829 |
| 63 | MP0008057_abnormal_DNA_replication | 0.78369853 |
| 64 | MP0002009_preneoplasia | 0.78243368 |
| 65 | MP0002277_abnormal_respiratory_mucosa | 0.78070566 |
| 66 | MP0002396_abnormal_hematopoietic_system | 0.76172492 |
| 67 | MP0004142_abnormal_muscle_tone | 0.74898245 |
| 68 | MP0005167_abnormal_blood-brain_barrier | 0.74772476 |
| 69 | MP0005174_abnormal_tail_pigmentation | 0.69946912 |
| 70 | MP0002693_abnormal_pancreas_physiology | 0.68228834 |
| 71 | MP0002837_dystrophic_cardiac_calcinosis | 0.65710292 |
| 72 | MP0004145_abnormal_muscle_electrophysio | 0.65207866 |
| 73 | MP0009765_abnormal_xenobiotic_induced | 0.64929975 |
| 74 | MP0000013_abnormal_adipose_tissue | 0.63554583 |
| 75 | MP0001986_abnormal_taste_sensitivity | 0.63199850 |
| 76 | MP0003787_abnormal_imprinting | 0.61388841 |
| 77 | MP0003303_peritoneal_inflammation | 0.61263791 |
| 78 | MP0001919_abnormal_reproductive_system | 0.61072805 |
| 79 | MP0004130_abnormal_muscle_cell | 0.60558415 |
| 80 | MP0000015_abnormal_ear_pigmentation | 0.60355159 |
| 81 | MP0004883_abnormal_blood_vessel | 0.60149004 |
| 82 | MP0001502_abnormal_circadian_rhythm | 0.59516228 |
| 83 | MP0005360_urolithiasis | 0.58590796 |
| 84 | MP0003172_abnormal_lysosome_physiology | 0.58301921 |
| 85 | MP0003690_abnormal_glial_cell | 0.58092420 |
| 86 | MP0005645_abnormal_hypothalamus_physiol | 0.55399199 |
| 87 | MP0002138_abnormal_hepatobiliary_system | 0.54537385 |
| 88 | MP0004036_abnormal_muscle_relaxation | 0.53806944 |
| 89 | MP0001765_abnormal_ion_homeostasis | 0.52748670 |
| 90 | MP0005164_abnormal_response_to | 0.52227260 |
| 91 | MP0004742_abnormal_vestibular_system | 0.51051006 |
| 92 | MP0005166_decreased_susceptibility_to | 0.50835025 |
| 93 | MP0002136_abnormal_kidney_physiology | 0.50267662 |
| 94 | MP0000427_abnormal_hair_cycle | 0.49148997 |
| 95 | MP0003075_altered_response_to | 0.48858446 |
| 96 | MP0000609_abnormal_liver_physiology | 0.48141300 |
| 97 | MP0002095_abnormal_skin_pigmentation | 0.48003738 |
| 98 | MP0005319_abnormal_enzyme/_coenzyme | 0.46698483 |
| 99 | MP0003795_abnormal_bone_structure | 0.45344750 |
| 100 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.42878686 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 8.60353272 |
| 2 | Abnormality of T cell number (HP:0011839) | 8.03296058 |
| 3 | Abnormality of T cells (HP:0002843) | 5.72885856 |
| 4 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 5.65422386 |
| 5 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.10782454 |
| 6 | Optic neuritis (HP:0100653) | 4.90437069 |
| 7 | Retrobulbar optic neuritis (HP:0100654) | 4.90437069 |
| 8 | IgG deficiency (HP:0004315) | 4.88681201 |
| 9 | Encephalitis (HP:0002383) | 4.79736310 |
| 10 | Severe combined immunodeficiency (HP:0004430) | 4.78400072 |
| 11 | Myositis (HP:0100614) | 4.68309636 |
| 12 | Chronic mucocutaneous candidiasis (HP:0002728) | 4.68093254 |
| 13 | Recurrent cutaneous fungal infections (HP:0011370) | 4.68093254 |
| 14 | Orchitis (HP:0100796) | 4.57147131 |
| 15 | Abnormality of eosinophils (HP:0001879) | 4.46581494 |
| 16 | Panhypogammaglobulinemia (HP:0003139) | 4.28682519 |
| 17 | Eczematoid dermatitis (HP:0000976) | 4.25037025 |
| 18 | Recurrent fungal infections (HP:0002841) | 4.22805514 |
| 19 | Hypoproteinemia (HP:0003075) | 4.03355774 |
| 20 | Recurrent viral infections (HP:0004429) | 3.97571047 |
| 21 | Eosinophilia (HP:0001880) | 3.92001196 |
| 22 | Increased IgM level (HP:0003496) | 3.83606430 |
| 23 | Combined immunodeficiency (HP:0005387) | 3.83362561 |
| 24 | Stomatitis (HP:0010280) | 3.82865619 |
| 25 | Chronic diarrhea (HP:0002028) | 3.82520011 |
| 26 | Meningitis (HP:0001287) | 3.81915724 |
| 27 | Leukocytosis (HP:0001974) | 3.79916264 |
| 28 | Gastrointestinal infarctions (HP:0005244) | 3.76201943 |
| 29 | Pustule (HP:0200039) | 3.68390677 |
| 30 | Autoimmune hemolytic anemia (HP:0001890) | 3.64746421 |
| 31 | Agammaglobulinemia (HP:0004432) | 3.62256599 |
| 32 | Granulocytopenia (HP:0001913) | 3.52117263 |
| 33 | Keratoconjunctivitis sicca (HP:0001097) | 3.50045624 |
| 34 | Thyroiditis (HP:0100646) | 3.49874241 |
| 35 | Recurrent bronchitis (HP:0002837) | 3.46962697 |
| 36 | Abnormality of T cell physiology (HP:0011840) | 3.45234087 |
| 37 | Vasculitis (HP:0002633) | 3.38959088 |
| 38 | Pulmonary infiltrates (HP:0002113) | 3.35737108 |
| 39 | Recurrent skin infections (HP:0001581) | 3.32218910 |
| 40 | Keratoconjunctivitis (HP:0001096) | 3.17862243 |
| 41 | Recurrent bacterial skin infections (HP:0005406) | 3.16691327 |
| 42 | Recurrent abscess formation (HP:0002722) | 3.13856193 |
| 43 | Hemoptysis (HP:0002105) | 3.01647909 |
| 44 | Abnormality of macrophages (HP:0004311) | 3.00760972 |
| 45 | Gangrene (HP:0100758) | 2.78024616 |
| 46 | Autoimmune thrombocytopenia (HP:0001973) | 2.74827013 |
| 47 | Hemiplegia (HP:0002301) | 2.71195739 |
| 48 | Inflammation of the large intestine (HP:0002037) | 2.63931495 |
| 49 | Hypoplasia of the thymus (HP:0000778) | 2.63834043 |
| 50 | Colitis (HP:0002583) | 2.63401106 |
| 51 | Mediastinal lymphadenopathy (HP:0100721) | 2.57700224 |
| 52 | Anorexia (HP:0002039) | 2.55919880 |
| 53 | Joint swelling (HP:0001386) | 2.54801650 |
| 54 | Abnormality of the pleura (HP:0002103) | 2.48063190 |
| 55 | Pulmonary embolism (HP:0002204) | 2.46608015 |
| 56 | Chest pain (HP:0100749) | 2.44346319 |
| 57 | Gastrointestinal inflammation (HP:0004386) | 2.41656843 |
| 58 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.41100573 |
| 59 | Lymphopenia (HP:0001888) | 2.40672338 |
| 60 | Arterial thrombosis (HP:0004420) | 2.40052598 |
| 61 | Bronchitis (HP:0012387) | 2.32589451 |
| 62 | Congenital stationary night blindness (HP:0007642) | 2.32400348 |
| 63 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.31787632 |
| 64 | Obstructive lung disease (HP:0006536) | 2.29392805 |
| 65 | Chronic obstructive pulmonary disease (HP:0006510) | 2.29392805 |
| 66 | Abnormality of the prostate (HP:0008775) | 2.28083748 |
| 67 | Keratitis (HP:0000491) | 2.27288411 |
| 68 | Hypergammaglobulinemia (HP:0010702) | 2.22232004 |
| 69 | Lymphoma (HP:0002665) | 2.20651240 |
| 70 | Increased IgE level (HP:0003212) | 2.14907323 |
| 71 | Abnormality of the pericardium (HP:0001697) | 2.02794612 |
| 72 | Cutaneous melanoma (HP:0012056) | 2.01763163 |
| 73 | Glomerulopathy (HP:0100820) | 2.00205883 |
| 74 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.98656706 |
| 75 | Spontaneous hematomas (HP:0007420) | 1.91407448 |
| 76 | Aplastic anemia (HP:0001915) | 1.90968307 |
| 77 | Abnormality of the endocardium (HP:0004306) | 1.90470884 |
| 78 | Increased CSF protein (HP:0002922) | 1.88077233 |
| 79 | Abnormality of the renal cortex (HP:0011035) | 1.86261694 |
| 80 | Metabolic alkalosis (HP:0200114) | 1.85366853 |
| 81 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.84632603 |
| 82 | Acute hepatic failure (HP:0006554) | 1.82932880 |
| 83 | Skin rash (HP:0000988) | 1.81893523 |
| 84 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.81252986 |
| 85 | Gingivitis (HP:0000230) | 1.81127224 |
| 86 | Dyschromatopsia (HP:0007641) | 1.79202059 |
| 87 | 3-Methylglutaconic aciduria (HP:0003535) | 1.77892101 |
| 88 | Hypoalbuminemia (HP:0003073) | 1.76707413 |
| 89 | Abnormal albumin level (HP:0012116) | 1.76707413 |
| 90 | Tetraplegia (HP:0002445) | 1.76564529 |
| 91 | Alveolar cell carcinoma (HP:0006519) | 1.74329614 |
| 92 | Hypokalemic alkalosis (HP:0001949) | 1.73687123 |
| 93 | Increased cerebral lipofuscin (HP:0011813) | 1.72927310 |
| 94 | Polyneuropathy (HP:0001271) | 1.71293993 |
| 95 | Renal cortical cysts (HP:0000803) | 1.68697287 |
| 96 | IgA deficiency (HP:0002720) | 1.67565664 |
| 97 | Petechiae (HP:0000967) | 1.67011491 |
| 98 | Acne (HP:0001061) | 1.66908742 |
| 99 | Abnormal spermatogenesis (HP:0008669) | 1.65361486 |
| 100 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.64491101 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 8.76100838 |
| 2 | MAP4K1 | 4.30306972 |
| 3 | EPHA3 | 3.01942513 |
| 4 | ITK | 2.77513658 |
| 5 | TAOK3 | 2.50998066 |
| 6 | FES | 2.34806359 |
| 7 | EPHB1 | 2.27817709 |
| 8 | CSK | 2.26077225 |
| 9 | JAK1 | 2.06350932 |
| 10 | IRAK4 | 2.00926622 |
| 11 | NLK | 1.90971883 |
| 12 | TNK2 | 1.89839234 |
| 13 | TESK2 | 1.89284856 |
| 14 | ZAP70 | 1.84418575 |
| 15 | FGFR4 | 1.77157983 |
| 16 | KDR | 1.76622776 |
| 17 | JAK3 | 1.72383866 |
| 18 | TGFBR2 | 1.70706027 |
| 19 | SYK | 1.70088034 |
| 20 | GRK7 | 1.66773630 |
| 21 | TYK2 | 1.66076133 |
| 22 | IRAK1 | 1.60569960 |
| 23 | BTK | 1.52223403 |
| 24 | IKBKB | 1.47096144 |
| 25 | RIPK4 | 1.40493689 |
| 26 | PRKCQ | 1.39865475 |
| 27 | BLK | 1.39080410 |
| 28 | LCK | 1.36435232 |
| 29 | MST4 | 1.31707815 |
| 30 | TEC | 1.30258573 |
| 31 | GRK6 | 1.26557373 |
| 32 | CSF1R | 1.25617469 |
| 33 | IKBKE | 1.21014485 |
| 34 | HCK | 1.14574722 |
| 35 | MAP3K14 | 1.12938252 |
| 36 | LYN | 1.12606850 |
| 37 | MAP2K3 | 1.11971137 |
| 38 | ZAK | 1.11439133 |
| 39 | PIK3CG | 1.06174911 |
| 40 | FGFR3 | 1.03739170 |
| 41 | CLK1 | 1.03228157 |
| 42 | STK10 | 1.03194839 |
| 43 | ADRBK2 | 0.97532046 |
| 44 | NEK9 | 0.91944549 |
| 45 | JAK2 | 0.90098326 |
| 46 | MAP3K3 | 0.85066542 |
| 47 | PDK1 | 0.77416821 |
| 48 | CAMKK2 | 0.77295359 |
| 49 | MAP3K10 | 0.74748997 |
| 50 | PIK3CA | 0.74460780 |
| 51 | MARK3 | 0.70905911 |
| 52 | NUAK1 | 0.68507860 |
| 53 | FYN | 0.65019024 |
| 54 | MAP3K12 | 0.64747763 |
| 55 | TLK1 | 0.63584017 |
| 56 | KIT | 0.61244288 |
| 57 | GRK5 | 0.59422476 |
| 58 | MAP3K11 | 0.58539218 |
| 59 | FRK | 0.58402008 |
| 60 | MAP3K13 | 0.58293602 |
| 61 | BMPR2 | 0.57795142 |
| 62 | TBK1 | 0.57608184 |
| 63 | RPS6KA5 | 0.56611815 |
| 64 | FER | 0.54876189 |
| 65 | DAPK2 | 0.54479326 |
| 66 | RET | 0.52336049 |
| 67 | CHUK | 0.51698797 |
| 68 | HIPK2 | 0.51645141 |
| 69 | PIM1 | 0.51403249 |
| 70 | MAPK12 | 0.50455607 |
| 71 | MAPKAPK2 | 0.50120334 |
| 72 | IGF1R | 0.46492991 |
| 73 | MAP2K6 | 0.45618134 |
| 74 | TYRO3 | 0.45433352 |
| 75 | DYRK1B | 0.44067039 |
| 76 | MAP3K1 | 0.41299122 |
| 77 | NEK6 | 0.40661369 |
| 78 | PTK6 | 0.39741053 |
| 79 | MOS | 0.39037021 |
| 80 | SGK2 | 0.37333513 |
| 81 | SGK3 | 0.35981327 |
| 82 | CAMKK1 | 0.35551428 |
| 83 | MAPK11 | 0.34315189 |
| 84 | INSR | 0.31496724 |
| 85 | PTK2B | 0.31184162 |
| 86 | TRPM7 | 0.30115082 |
| 87 | WNK4 | 0.29742042 |
| 88 | PASK | 0.28751228 |
| 89 | ADRBK1 | 0.28567759 |
| 90 | PRKCD | 0.26820300 |
| 91 | PDGFRB | 0.25668787 |
| 92 | AKT3 | 0.23973008 |
| 93 | FGR | 0.21881758 |
| 94 | MATK | 0.20963215 |
| 95 | EIF2AK2 | 0.20901630 |
| 96 | DAPK1 | 0.20276884 |
| 97 | FGFR1 | 0.18267388 |
| 98 | MAP4K2 | 0.17998153 |
| 99 | PRKCH | 0.17025083 |
| 100 | ERN1 | 0.16925709 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 6.09383220 |
| 2 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 4.34285492 |
| 3 | * Antigen processing and presentation_Homo sapiens_hsa04612 | 4.09872184 |
| 4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.75113550 |
| 5 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 3.24596319 |
| 6 | Allograft rejection_Homo sapiens_hsa05330 | 3.18261094 |
| 7 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.07107046 |
| 8 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.63301003 |
| 9 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.50765701 |
| 10 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.47711285 |
| 11 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.47295349 |
| 12 | Measles_Homo sapiens_hsa05162 | 2.36921917 |
| 13 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.27055541 |
| 14 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.78700831 |
| 15 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.77640380 |
| 16 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.76255940 |
| 17 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.67802517 |
| 18 | Malaria_Homo sapiens_hsa05144 | 1.66879172 |
| 19 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.66665943 |
| 20 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.62458925 |
| 21 | Leishmaniasis_Homo sapiens_hsa05140 | 1.55112709 |
| 22 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.54472102 |
| 23 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.53642048 |
| 24 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.42143165 |
| 25 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.35020270 |
| 26 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.30919042 |
| 27 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.30594801 |
| 28 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.23019877 |
| 29 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.21033411 |
| 30 | Viral myocarditis_Homo sapiens_hsa05416 | 1.16363771 |
| 31 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.02315467 |
| 32 | Apoptosis_Homo sapiens_hsa04210 | 1.01918359 |
| 33 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.01572345 |
| 34 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.99311253 |
| 35 | Tuberculosis_Homo sapiens_hsa05152 | 0.97869243 |
| 36 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.88601747 |
| 37 | Legionellosis_Homo sapiens_hsa05134 | 0.84884993 |
| 38 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.84373551 |
| 39 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.84248397 |
| 40 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.84201421 |
| 41 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.82785715 |
| 42 | Platelet activation_Homo sapiens_hsa04611 | 0.76007403 |
| 43 | Influenza A_Homo sapiens_hsa05164 | 0.74985231 |
| 44 | Proteasome_Homo sapiens_hsa03050 | 0.71997593 |
| 45 | Salmonella infection_Homo sapiens_hsa05132 | 0.71951460 |
| 46 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.70961810 |
| 47 | Asthma_Homo sapiens_hsa05310 | 0.65616083 |
| 48 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.62245942 |
| 49 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.60729101 |
| 50 | Phototransduction_Homo sapiens_hsa04744 | 0.60073045 |
| 51 | HTLV-I infection_Homo sapiens_hsa05166 | 0.58727427 |
| 52 | Hepatitis B_Homo sapiens_hsa05161 | 0.56380883 |
| 53 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.56036573 |
| 54 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.50100980 |
| 55 | Hepatitis C_Homo sapiens_hsa05160 | 0.49668466 |
| 56 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.48036235 |
| 57 | Pertussis_Homo sapiens_hsa05133 | 0.47469351 |
| 58 | Shigellosis_Homo sapiens_hsa05131 | 0.47030250 |
| 59 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.44142167 |
| 60 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.43372497 |
| 61 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.41083067 |
| 62 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.40637751 |
| 63 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.40523025 |
| 64 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.37776730 |
| 65 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.35489096 |
| 66 | Olfactory transduction_Homo sapiens_hsa04740 | 0.34843594 |
| 67 | Endocytosis_Homo sapiens_hsa04144 | 0.34405972 |
| 68 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.33824907 |
| 69 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.33746814 |
| 70 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.31358180 |
| 71 | ABC transporters_Homo sapiens_hsa02010 | 0.30519686 |
| 72 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.29762031 |
| 73 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.28642474 |
| 74 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.27109133 |
| 75 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.26483229 |
| 76 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.26166255 |
| 77 | Phagosome_Homo sapiens_hsa04145 | 0.24024239 |
| 78 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.23407401 |
| 79 | Circadian rhythm_Homo sapiens_hsa04710 | 0.23277160 |
| 80 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.22843190 |
| 81 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.19757066 |
| 82 | Renin secretion_Homo sapiens_hsa04924 | 0.19632487 |
| 83 | Insulin resistance_Homo sapiens_hsa04931 | 0.19389936 |
| 84 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.18047055 |
| 85 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.17993195 |
| 86 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.17158370 |
| 87 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.17142284 |
| 88 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.16998656 |
| 89 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.14506729 |
| 90 | Lysosome_Homo sapiens_hsa04142 | 0.13374340 |
| 91 | Morphine addiction_Homo sapiens_hsa05032 | 0.11890950 |
| 92 | Prion diseases_Homo sapiens_hsa05020 | 0.10806912 |
| 93 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.08923309 |
| 94 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.08637014 |
| 95 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.08116530 |
| 96 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.07961643 |
| 97 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.07465207 |
| 98 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.07094589 |
| 99 | RNA degradation_Homo sapiens_hsa03018 | 0.06664283 |
| 100 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.05652472 |

